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We, Should We, and Would We?As we enter the era of multimodality imaging, we are presented
with a barrage of imaging modalities, which at times offer
comparable or even overlapping clinical solutions. Technological
advancements have also brought new life to established imaging
modalities such as ultrasound. Recent studies have shown that
4D contrast enhanced ultrasound could possibly assess fenes-
trated endovascular aneurysm in the future,1 while 3D ultra-
sound has been shown to accurately diagnose endoleaks and
assess abdominal aortic aneurysm diameter.2 Whether we can
capitalise on the various imaging modalities depends on a good
understanding of the pros and cons of each modality, as well as
sound clinical judgement.
Ultrasound retains its appeal in the era of multimodality im-
aging because of its relatively low cost, easy availability, and
safety. However, when it comes to diagnosing thoracic aortic
pathology, its widespread use has been hampered by limitations
such as poor far ﬁeld resolution and difﬁcult imaging windows
because of patient’s body habitus, presence of lung tissue, or ribs.
Consequently, imaging modalities such as computed tomographic
angiography and magnetic resonance angiography, which offer
multiplanar reconstruction, comprehensive coverage, superior
image quality and ability to depict ﬁne details, such as thrombus
formation, aortic dissection entry site, or endoleaks, are
becoming increasingly commonplace in routine clinical practice.
Published guidelines on multimodality imaging of the thoracic
aorta, for example the European Association of Cardiovascular
Imaging/American Society of Echocardiography Guidelines pub-
lished in 2015 and the latest Clinical Practice Guidelines by the
European Society of Vascular Surgery (ESVS) published in 2017,
provided similar recommendations on the topic of thoracic
aortic imaging.3,4 Both guidelines acknowledge the use of
transthoracic echocardiography (TTE) as a useful tool for eval-
uating the aortic root, ascending aorta, and aortic arch in pa-
tients with good acoustic windows. However, TTE is deemed less
useful for evaluating the descending aorta as TTE cannot reliably
evaluate the entire thoracic aorta in patients with suspected
aortic disease.3 Currently, multidetector computed tomographic
(CT) angiography is the ﬁrst line diagnostic modality for
descending aorta pathology (Class I, Level of evidence C), while
transoesophageal echocardiography (TOE) is considered the
second line imaging modality when CT is unavailable, contra-
indicated, or inconclusive (Class IIa, Level of evidence C).4
In the work by D’abate et al., the authors examined the
feasibility of transthoracic ultrasound for imaging the descend-
ing thoracic aorta using a dedicated protocol.5 The studyDOI of original article: https://doi.org/10.1016/j.ejvs.2017.12.012.
1078-5884/ 2018 European Society for Vascular Surgery. Published by
Elsevier Ltd. All rights reserved.
10.1016/j.ejvs.2018.02.007
Please cite this article in press as: Go YY, Transthoracic Ultrasound Imaging of
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possibility of ultrasound being an alternative to CT angiography,
especially in patients who required annual surveillance CT scans.
The authors also outlined a protocol comprising four acoustic
windows, namely the suprasternal, parasternal long axis, apical
two chamber, and subcostal windows to assess the descending
thoracic aorta. In fact, these imaging windows are not novel.
They have been described in major echocardiographic textbooks
and society guidelines,6,7 albeit not routinely performed or re-
ported for two reasons. First, these imaging windows may not be
reliably acquired in all patients. Also, TTE has been shown to
perform poorly at detecting descending thoracic aortic pathol-
ogy compared with TOE, CT, and magnetic resonance imaging
(MRI).8 A previous study, which included 78 patients who un-
derwent TTE, reported a 40.0% sensitivity of TTE at detecting
acute Type B aortic dissection and the sensitivity dropped to
29.4% for subacute Type B dissection.8 In the study, TTE could
detect the site of entry in only 26.2% of the cases and thrombus
formation in 11.8%.While the sensitivity of detecting acute Type
B aortic dissection was 100% for TOE, CT, and MRI. In the case of
subacute Type B aortic dissection, the detection sensitivity was
100% for TOE, 93.3% for CT, and 94.4% for MRI. In comparison,
D’abate and colleagues were able to obtain technically complete
assessment in 18 out of 39 (46%) patients, and partial assess-
ment in 20 out of 39 (51%) patients, which left a lot to be
desired, even by the standard set by the authors: that a ‘satis-
factory’ image was deﬁned by visualising at least two of the
three regions of descending aorta, while ‘partially satisfactory’
was deﬁned as obtaining just one view. The authors also tested
the sensitivity and speciﬁcity of using 35 mm and 40 mm as
cutoffs for descending thoracic aortic dilatation, although it is
not entirely clear how the thresholds were chosen or their
prognostic signiﬁcance. Studies of the natural history of thoracic
aortic aneurysm have shown that the risk of rupture increased
when the aortic diameter was more than 6 cm,9 while a diam-
eter over 5 cm is considered aneurysmal and diameter above
4 cm is called dilatation.10
This brings us to the three pertinent aspects that we ought to
ask ourselves while choosing any imaging modality: could we,
should we, and would we? The fact that one could use ultra-
sound to image the descending thoracic aorta, albeit not
consistently, does not mean that one should embrace it in a non-
discriminatory manner. Its inability to image the entire length of
the aorta reliably means that it does not have the diagnostic
certainty to be a standalone test, especially when the clinical
stakes are high and the consequence of missing the diagnosis is
catastrophic.11 The idea of using ultrasound as a gatekeeper to
CT scan is plausible, although its cost-effectiveness is doubtful as
patients will be subjected to multiple testing and the proportion
of patients with non-conclusive ultrasound reports is notthe Descending Thoracic Aorta: Could We, Should We, and Would We?,
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2 Editorialnegligible. However, just because we should not use TTE in some
clinical scenarios does not mean that we would not use it at all.
A thoracic aortic ultrasound protocol could be a useful adjunct
to focused assessment with sonography for trauma (FAST),
performed by the emergency physicians, trauma surgeons, or
other trained operators. Aortic imaging can also be incorporated
into routine TTE examination in patients with a history of aortic
pathology.6 As an adjunctive protocol, it adds value to the ul-
trasound examination, although a negative test in the context of
high clinical suspicion still warrants further, more deﬁnitive im-
aging, such as CT angiography.
One major impetus for seeking an alternative imaging mo-
dality to the current gold standard of CT angiography, is that CT
carries the risk of radiation exposure and contrast induced ne-
phropathy in patients with renal impairment. To put things into
perspective, the effective dose of high pitch CT angiography
approximates 10 mSV,12 which is comparable with natural
background radiation for 3 years. The risk of death from cancer
associated with this radiation dose range is comparable with
driving 2000 miles, that is driving from the East to the West
coast of the United States (1 in 104 chance of death).13,14 For a
non-invasive imaging alternative without ionising radiation, MR
angiography, often performed without contrast is an ideal
alternative to CT angiography for serial imaging, or imaging in
pregnant or paediatric subjects.
Now more than ever, we have the opportunity of choosing
from various imaging modalities to answer the clinical question
at hand. With opportunity of course, comes responsibility. The
onus is on us to exercise it wisely, selecting the modality that
best suits the clinical context, the one most likely to clinch a
deﬁnitive diagnosis, the most cost-effective, least invasive if
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